On October 2, 2024 (U.S. Eastern Time), Baird Medical successfully listed on the Nasdaq Stock Market, marking a significant milestone in its international growth strategy. This listing reinforces the Company's commitment to innovation, global market expansion, and enhancing shareholder value as it continues to pioneer cutting-edge medical solutions. PatentsIn 2024, Baird Medical further expanded its intellectual property portfolio, securing patents that enhance MWA technology and production efficiency: Inve ...

The NASIT Conference is a premier forum for education, research, and collaboration in thyroid interventions, and Baird Medical is honored to participate in this key industry event. The Company's invitation highlights its growing prominence in the field of microwave ablation while offering a valuable opportunity to engage with global experts, industry leaders, and potential partners. As a returning participant, Baird Medical is excited to contribute to discussions on the latest advancements in MWA technology ...

NEW YORK, Jan. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation technology (MWA), announced today that it will participate in the highly anticipated Microcap Conference, set to take place at the Borgata Hotel in Atlantic City, New Jersey, from January 28 to January 30, 2025. Baird Medical specializes in the design and development of cutting-edge needles and apparatus for microwave ablation of thyroid nodules. Th ...

NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, is expanding its presence into San Francisco, marking an important step in its U.S. growth strategy. This expansion follows the recent J.P. Morgan Health Conference in San Francisco, highlighting the company's early success in executing its strategic vision for medical innovation. As part of this development, Dr. ...

Following its successful debut on Nasdaq in October 2024, Baird Medical connected with healthcare investors and industry leaders during the week of the conference, engaging in meaningful discussions on the company's advancements in microwave ablation technology and its commitment to improving patient outcomes. "Being in San Francisco during the J.P. Morgan Healthcare Conference provided a valuable opportunity to engage with shareholders, innovators, and advisors in the healthcare sector," said Haimei Wu, Ch ...

Led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, the session welcomed participation from Dr. Sean P. Nikravan, MD, FACE, an endocrinologist based in Newport Beach, CA, and Dr. Erin H. Lin, DO, a specialist in Surgical Oncology and General Surgery from the University of California, Irvine. Both physicians had the opportunity to observe seven live MWA procedures, refine advanced techniques, and evaluate the unique capabilities of this groundbreaking t ...

NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leading innovator in minimally invasive microwave ablation (MWA) technology, proudly supported and participated in the 2024 Guangdong Provincial Parathyroid Disease - Southern Yue Forum, held in Guangzhou, China. This distinguished forum, organized by prominent healthcare institutions in Guangdong, brought together esteemed medical experts, researchers, and healthcare professionals to share insights on advancements in the diagnosis and ...

Throughout the two-day event, Baird Medical showcased its latest advancements in thyroid treatment, particularly focusing on its microwave ablation (MWA) technology. The forum brought together leading experts and healthcare professionals to discuss innovations in endoscopic and minimally invasive surgery, fostering the exchange of ideas and best practices. "The Guangdong Thyroid Surgery Committee Annual Meeting is an ideal platform for sharing our latest advancements in thyroid ablation," said Haimei Wu, Ch ...

Led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, the program welcomed Dr. Ernest O. Asamoah, an endocrinologist from Indianapolis, IN, and Dr. John W. Sistrunk, an endocrinologist from Jackson, MS. Both physicians observed seven live MWA cases, participated in in-depth discussions, and engaged in hands-on practice with the equipment. Dr. Kandil, who has performed over 80 MWA procedures, recently presented at the American Thyroid Association (ATA) an ...

NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in microwave ablation technology, proudly participated in the recent Massachusetts Society of Otolaryngology (MSO) event. This year's event centered on emerging trends in Otolaryngology, with a focus on the increasing shift toward office-based surgical procedures.The MSO is a distinguished organization dedicated to promoting the professional interests of Otolaryngologists in Massachusetts. It provides vital resources on practice ...